Internal Medicine, Infectious Disease · Huntsville, AL
NPI
1063404978
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
420 Lowell Dr SE, Suite 301
Huntsville, AL, 35801
Phone (256) 265-7955
Groups this clinician bills Medicare through
Medicare paid, 2024
$209K
3,070 services
Medicare patients, 2024
522
Average age 75
Drug cost, 2024
$1.4M
1,747 prescriptions
Company payments, 2025
$51K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali A Hassoun was code 99232 (hospital e&m - subsequent), 2,027 times for 352 patients. In total Ali A Hassoun billed 3,070 services in 7 codes, and Medicare paid $209K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,027 | 352 | $55.32 | $112K |
| 99214 Office E&M - Established | Office | 591 | 249 | $85.54 | $51K |
| 99222 Hospital E&M - Initial | Facility | 338 | 299 | $94.01 | $32K |
| 99204 Office E&M - New | Office | 52 | 52 | $108.23 | $5,628 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 52 | 51 | $160.33 | $8,337 |
By year: 2022 $209K for 3,077 services; 2023 $187K for 2,654 services; 2024 $209K for 3,070 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ali A Hassoun prescribed most often to Medicare patients was Daptomycin, with 387 prescriptions and refills. In total Ali A Hassoun wrote 1,747 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 387 | 387 | 80 | $197K |
| Cefepime Hcl Generic | 217 | 217 | 55 | $40K |
| Tobramycin Sulfate Generic | 120 | 120 | 16 | $2,701 |
| Aztreonam Generic | 80 | 80 | Under 11 | $41K |
| Doxycycline Hyclate Generic | 76 | 108 | 23 | $3,185 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 67 | 76 | Under 11 | $308K |
| Sodium Chloride 0.9 % Sodium Chloride | 60 | 60 | 13 | $690 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 49 | 49 | 16 | $8,125 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 44 | 46 | Under 11 | $168K |
| Ethambutol Hcl Generic | 40 | 54 | Under 11 | $2,455 |
| Ertapenem Ertapenem Sodium | 39 | 39 | 13 | $20K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 36 | 36 | Under 11 | $138K |
| Meropenem Generic | 36 | 36 | Under 11 | $7,435 |
| Rifampin Generic | 36 | 42 | Under 11 | $2,713 |
| Epinephrine Generic | 35 | 35 | 35 | $9,036 |
Brand drugs: 366 claims; generic drugs: 1,381 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali A Hassoun $51K ($51K in general payments such as food, travel and fees) from 13 companies. The largest payer was Pfizer Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $30K |
| Melinta Therapeutics, LLC | 14 | $7,837 |
| Astellas Pharma US Inc 4503.T | 8 | $5,068 |
| GlaxoSmithKline, LLC. GSK | 3 | $3,273 |
| Cumberland Pharmaceuticals, Inc. CPIX | 21 | $2,810 |
| La Jolla Pharmaceutical Company | 4 | $1,820 |
| Abbvie Inc. ABBV | 21 | $446 |
| Insmed, Inc. INSM | 15 | $254 |
| Merck Sharp & Dohme LLC MRK | 4 | $105 |
| Aimmune Therapeutics, Inc. | 3 | $61.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.